Woodstock Corp Sells 561 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Woodstock Corp decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.5% in the 1st quarter, HoldingsChannel reports. The firm owned 5,361 shares of the company’s stock after selling 561 shares during the quarter. Woodstock Corp’s holdings in GE HealthCare Technologies were worth $487,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in GE HealthCare Technologies by 14.7% during the 3rd quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock worth $3,029,917,000 after buying an additional 5,693,244 shares in the last quarter. Norges Bank acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth approximately $229,052,000. Capital Research Global Investors grew its stake in shares of GE HealthCare Technologies by 2.8% during the fourth quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock valued at $3,969,975,000 after purchasing an additional 1,401,566 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of GE HealthCare Technologies by 84.4% in the third quarter. Ameriprise Financial Inc. now owns 2,668,695 shares of the company’s stock valued at $181,578,000 after purchasing an additional 1,221,436 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its position in GE HealthCare Technologies by 1,323.5% in the 3rd quarter. Envestnet Asset Management Inc. now owns 1,024,128 shares of the company’s stock worth $69,682,000 after purchasing an additional 952,182 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent research reports. Mizuho decreased their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Bank of America decreased their price target on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Argus boosted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Evercore ISI upped their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Finally, Citigroup lifted their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $94.09.

GE HealthCare Technologies Trading Up 1.9 %

GE HealthCare Technologies stock traded up $1.49 during midday trading on Thursday, hitting $79.76. 805,210 shares of the stock were exchanged, compared to its average volume of 3,138,737. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. The stock has a market capitalization of $36.41 billion, a PE ratio of 22.89, a P/E/G ratio of 2.81 and a beta of 1.22. The company has a fifty day simple moving average of $80.85 and a two-hundred day simple moving average of $81.33.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The company had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same period last year, the firm posted $0.85 earnings per share. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were issued a $0.03 dividend. The ex-dividend date of this dividend was Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Insider Transactions at GE HealthCare Technologies

In related news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares in the company, valued at approximately $5,296,510. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now directly owns 67,300 shares in the company, valued at $5,296,510. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jan Makela sold 66,955 shares of the company’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the completion of the transaction, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at $5,165,395.92. The disclosure for this sale can be found here. Insiders have sold a total of 90,482 shares of company stock valued at $7,369,137 over the last 90 days. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.